Mark Strobeck Rockwell Medical, Inc. (RMTI) insider trading activity

Mark Strobeck is President and CEO of ROCKWELL MEDICAL, INC.. Currently has a direct ownership of 131,604 shares of RMTI, which is worth approximately $231,623. The most recent transaction as insider was on Mar 17, 2025, when has been sold 6,101 shares (Common Stock) at a price of $1.77 per share, resulting in proceeds of $10,798. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 132K

10.6% 3M change

11.89% 12M change

Total Value Held $231,623

Mark Strobeck Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 17 2025	SELL Payment of exercise price or tax liability	$10,798 $1.77 p/Share	6,101 Reduced 4.43%	131,604 Common Stock
Mar 14 2025	SELL Payment of exercise price or tax liability	$12,466 $1.7 p/Share	7,333 Reduced 5.06%	137,705 Common Stock
Jan 02 2025	SELL Open market or private sale	$4,455 $2.06 p/Share	2,163 Reduced 1.47%	145,038 Common Stock
Oct 01 2024	SELL Open market or private sale	$7,981 $3.69 p/Share	2,163 Reduced 1.45%	147,201 Common Stock
Mar 17 2024	SELL Payment of exercise price or tax liability	$8,541 $1.4 p/Share	6,101 Reduced 3.92%	149,364 Common Stock
Mar 14 2024	BUY Grant, award, or other acquisition	-	100,000 Added 39.14%	155,465 Common Stock
Mar 17 2023	BUY Grant, award, or other acquisition	-	55,465 Added 50.0%	55,465 Common Stock

Also insider at

WINT

WINDTREE THERAPEUTICS INC Healthcare

Director

Mark Strobeck

President and CEO

Wixom, MI

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RMTI shares.

Notify only if

Value

Insider Trading

Get notified when an Rockwell Medical, Inc. insider buys or sells RMTI shares.

Notify only if

Operation

Value

Type

News

Receive news related to ROCKWELL MEDICAL, INC.

Track Activities on RMTI

Account